Search Results

There are 28432 results for: content related to: Adding pharmacists to primary care teams reduces predicted long-term risk of cardiovascular events in Type 2 diabetic patients without established cardiovascular disease: results from a randomized trial

  1. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus

    Intervention Review

    The Cochrane Library

    Bianca Hemmingsen, Søren S Lund, Christian Gluud, Allan Vaag, Thomas P Almdal and Jørn Wetterslev

    Published Online : 11 NOV 2013, DOI: 10.1002/14651858.CD008143.pub3

  2. Coronary heart disease risk assessment in diabetes mellitus: comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications

    Diabetic Medicine

    Volume 21, Issue 3, March 2004, Pages: 238–245, S. H. Song and P. M. Brown

    Article first published online : 22 JAN 2004, DOI: 10.1111/j.1464-5491.2004.01116.x

  3. You have free access to this content
    Sulphonylurea monotherapy for patients with type 2 diabetes mellitus

    Intervention Review

    The Cochrane Library

    Bianca Hemmingsen, Jeppe B Schroll, Søren S Lund, Jørn Wetterslev, Christian Gluud, Allan Vaag, David Peick Sonne, Lars H Lundstrøm and Thomas P Almdal

    Published Online : 30 APR 2013, DOI: 10.1002/14651858.CD009008.pub2

  4. Impact of the UKPDS—an overview

    Diabetic Medicine

    Volume 25, Issue s2, August 2008, Pages: 2–8, P. D. Home

    Article first published online : 18 JUL 2008, DOI: 10.1111/j.1464-5491.2008.02501.x

  5. UKPDS—modelling of cardiovascular risk assessment and lifetime simulation of outcomes

    Diabetic Medicine

    Volume 25, Issue s2, August 2008, Pages: 41–46, A. I. Adler

    Article first published online : 18 JUL 2008, DOI: 10.1111/j.1464-5491.2008.02498.x

  6. Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study

    Diabetic Medicine

    Volume 22, Issue 5, May 2005, Pages: 554–562, R. N. Guzder, W. Gatling, M. A. Mullee, R. L. Mehta and C. D. Byrne

    Article first published online : 18 APR 2005, DOI: 10.1111/j.1464-5491.2005.01494.x

  7. The UKPDS and its global impact

    Diabetic Medicine

    Volume 25, Issue s2, August 2008, Pages: 57–62, S. Genuth

    Article first published online : 18 JUL 2008, DOI: 10.1111/j.1464-5491.2008.02504.x

  8. You have full text access to this OnlineOpen article
    Comparison of four cardiovascular risk prediction functions among Chinese patients with diabetes mellitus in the primary care setting

    Journal of Diabetes Investigation

    Volume 5, Issue 5, September 2014, Pages: 606–614, Fang Fang Jiao, Cindy Lo Kuen Lam, Colman Fung and Sarah Morag McGhee

    Article first published online : 11 FEB 2014, DOI: 10.1111/jdi.12188

  9. Cardiovascular risk profile of subjects with known diabetes from the middle- and high-income group population of Delhi: the DEDICOM survey

    Diabetic Medicine

    Volume 25, Issue 1, January 2008, Pages: 27–36, J. Nagpal and A. Bhartia

    Article first published online : 19 NOV 2007, DOI: 10.1111/j.1464-5491.2007.02307.x

  10. The economic analyses of the UK prospective diabetes study

    Diabetic Medicine

    Volume 25, Issue s2, August 2008, Pages: 47–51, A. M. Gray and P. Clarke

    Article first published online : 18 JUL 2008, DOI: 10.1111/j.1464-5491.2008.02502.x

  11. You have full text access to this OnlineOpen article
    Does early intensive multifactorial therapy reduce modelled cardiovascular risk in individuals with screen-detected diabetes? Results from the ADDITION-Europe cluster randomized trial

    Diabetic Medicine

    Volume 31, Issue 6, June 2014, Pages: 647–656, J. A. Black, S. J. Sharp, N. J. Wareham, A. Sandbæk, G. E. H. M. Rutten, T. Lauritzen, K. Khunti, M. J. Davies, K. Borch-Johnsen, S. J. Griffin and R. K. Simmons

    Article first published online : 1 APR 2014, DOI: 10.1111/dme.12410

  12. Skin autofluorescence and risk of micro- and macrovascular complications in patients with Type 2 diabetes mellitus—a multi-centre study

    Diabetic Medicine

    Volume 29, Issue 12, December 2012, Pages: 1556–1561, M. J. Noordzij, D. J. Mulder, P. H. N. Oomen, T. Brouwer, J. Jager, M. Castro Cabezas, J. D. Lefrandt and A. J. Smit

    Article first published online : 14 NOV 2012, DOI: 10.1111/dme.12005

  13. You have free access to this content
    How much might cardiovascular disease risk be reduced by intensive therapy in people with screen-detected diabetes?

    Diabetic Medicine

    Volume 25, Issue 12, December 2008, Pages: 1433–1439, J. B. Echouffo-Tcheugui, L. A. Sargeant, A. T. Prevost, K. M. Williams, R. S. Barling, R. Butler, T. Fanshawe, A. L. Kinmonth, N. J. Wareham and S. J. Griffin

    Article first published online : 1 OCT 2008, DOI: 10.1111/j.1464-5491.2008.02600.x

  14. Microvascular disease: what does the UKPDS tell us about diabetic nephropathy?

    Diabetic Medicine

    Volume 25, Issue s2, August 2008, Pages: 25–29, R. Bilous

    Article first published online : 18 JUL 2008, DOI: 10.1111/j.1464-5491.2008.02496.x

  15. Metformin monotherapy for type 2 diabetes mellitus

    Intervention Review

    The Cochrane Library

    Antonio Saenz, Inmaculada Fernandez-Esteban, Angel Mataix, Monica Ausejo Segura, Marta Roqué i Figuls and David Moher

    Published Online : 20 JUL 2005, DOI: 10.1002/14651858.CD002966.pub3

  16. The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65)

    Diabetic Medicine

    Volume 20, Issue 6, June 2003, Pages: 442–450, P. Clarke, A. Gray, R. Legood, A. Briggs and R. Holman

    Article first published online : 18 JUL 2003, DOI: 10.1046/j.1464-5491.2003.00972.x

  17. Ethnicity and long-term vascular outcomes in Type 2 diabetes: a prospective observational study (UKPDS 83)

    Diabetic Medicine

    Volume 31, Issue 2, February 2014, Pages: 200–207, T. M. E. Davis, R. L. Coleman, R. R. Holman and UKPDS Group

    Article first published online : 22 NOV 2013, DOI: 10.1111/dme.12353

  18. You have free access to this content
    Efficacy of a Pharmacist-Led Cardiovascular Risk Reduction Clinic for Diabetic Patients With and Without Mental Health Conditions

    Preventive Cardiology

    Volume 11, Issue 4, Fall 2008, Pages: 195–200, Tracey H. Taveira, Paul A. Pirraglia, Lisa B. Cohen and Wen-Chih Wu

    Article first published online : 15 OCT 2008, DOI: 10.1111/j.1751-7141.2008.00008.x

  19. Autoantibodies to the islet cell antigen SOX-13 are associated with duration but not type of diabetes

    Diabetic Medicine

    Volume 20, Issue 3, March 2003, Pages: 198–204, T. M. E. Davis, Z. Mehta, I. R. Mackay, C. A. Cull, D. G. Bruce, S. Fida, M. J. Rowley and R. R. Holman

    Article first published online : 10 MAR 2003, DOI: 10.1046/j.1464-5491.2003.00897.x

  20. Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus

    Intervention Review

    The Cochrane Library

    Bernd Richter, Elizabeth Bandeira-Echtler, Karla Bergerhoff and Christian Lerch

    Published Online : 23 APR 2008, DOI: 10.1002/14651858.CD006739.pub2